Click Here to return To Results

 

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2 NEJM 361:358-367, Plotkin,S.R.,et al, 2009 See this aricle in Pubmed Article Abstract VEGF blockage with bevacizumab improved hearing in some, but not all, patients with neurofibromatosis type 2 and was associated with a reduction in the volume of most growing vestibular schwannomas.

Related Tags

(click to filter results - removes previous filter) acoustic neurinoma bevacizumab hearing loss monoclonal antibodies neurofibromatosis 2 schwannoma treatment of neurologic disorder vascular endothelial growth factor

Click Here to return To Results